Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Acute Kidney Injury | Research article

The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study

Authors: Kirsty Andresen, Helena Carreira, Helen Strongman, Helen I. McDonald, Sara Benitez-Majano, Kathryn E. Mansfield, Dorothea Nitsch, Laurie A. Tomlinson, Krishnan Bhaskaran

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Colorectal cancer survival has improved in recent decades but there are concerns that survivors may develop kidney problems due to adverse effects of cancer treatment or complications of the cancer itself. We quantified the risk of acute kidney injury (AKI) in colorectal cancer survivors compared to people with no prior cancer.

Methods

Retrospective matched cohort study using electronic health record primary care data from the Clinical Practice Research Datalink GOLD linked to hospital data in England (HES-APC). Individuals with colorectal cancer between 1997–2018 were individually matched on age, sex, and GP practice to people with no prior cancer. We used Cox models to estimate hazard ratios for an incident hospital diagnosis of AKI in colorectal cancer survivors compared to individuals without cancer, overall and stratified by time since diagnosis adjusted for other individual-level factors (adj-HR).

Results

Twenty thousand three hundred forty colorectal cancer survivors were matched to 100,058 cancer-free individuals. Colorectal cancer survivors were at increased risk of developing AKI compared to people without cancer (adj-HR = 2.16; 95%CI 2.05–2.27). The HR was highest in the year after diagnosis (adj-HR 7.47, 6.66–8.37), and attenuated over time, but there was still increased AKI risk > 5 years after diagnosis (adj-HR = 1.26, 1.17–1.37). The association between colorectal cancer and AKI was greater for younger people, men, and those with pre-existing chronic kidney disease.

Conclusions

Colorectal cancer survivors were at increased risk of AKI for several years after cancer diagnosis, suggesting a need to prioritise monitoring, prevention, and management of kidney problems in this group of cancer survivors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–32.CrossRefPubMed Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–32.CrossRefPubMed
2.
go back to reference Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sorensen HT. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med. 2011;22(4):399–406.CrossRefPubMed Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sorensen HT. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med. 2011;22(4):399–406.CrossRefPubMed
3.
go back to reference Rosner MH, Perazella MA. Acute kidney injury in patients with cancer. N Engl J Med. 2017;376(18):1770–81.CrossRefPubMed Rosner MH, Perazella MA. Acute kidney injury in patients with cancer. N Engl J Med. 2017;376(18):1770–81.CrossRefPubMed
4.
go back to reference Libório AB, Abreu KL, Silva GB Jr, Lima RS, Barreto AG, Barbosa OA, et al. Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity. Oncology. 2011;80(3–4):160–6.CrossRefPubMed Libório AB, Abreu KL, Silva GB Jr, Lima RS, Barreto AG, Barbosa OA, et al. Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity. Oncology. 2011;80(3–4):160–6.CrossRefPubMed
6.
go back to reference Macmillan Cancer Support. Cured - but at what cost? Long term consequences of cancer and its treatment. 2013. Macmillan Cancer Support. Cured - but at what cost? Long term consequences of cancer and its treatment. 2013.
7.
go back to reference Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, et al. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer. 2010;116(17):4063–8.CrossRefPubMed Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, et al. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer. 2010;116(17):4063–8.CrossRefPubMed
8.
go back to reference Eckman LN, Lynch EC. Acute renal failure in patients with acute leukemia. South Med J. 1978;71(4):382–5.CrossRefPubMed Eckman LN, Lynch EC. Acute renal failure in patients with acute leukemia. South Med J. 1978;71(4):382–5.CrossRefPubMed
9.
go back to reference Lameire NH, Flombaum CD, Moreau D, Ronco C. Acute renal failure in cancer patients. Ann Med. 2005;37(1):13–25.CrossRefPubMed Lameire NH, Flombaum CD, Moreau D, Ronco C. Acute renal failure in cancer patients. Ann Med. 2005;37(1):13–25.CrossRefPubMed
10.
go back to reference Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010;55(5 Suppl 3):S1-13; quiz S4-9.CrossRefPubMed Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010;55(5 Suppl 3):S1-13; quiz S4-9.CrossRefPubMed
11.
12.
go back to reference Slagelse C, Gammelager H, Iversen LH, Sorensen HT, Christiansen CF. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study. BMJ Open. 2019;9(3):e024817.CrossRefPubMedPubMedCentral Slagelse C, Gammelager H, Iversen LH, Sorensen HT, Christiansen CF. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study. BMJ Open. 2019;9(3):e024817.CrossRefPubMedPubMedCentral
13.
go back to reference Li L, Lau KS, Ramanathan V, Orcutt ST, Sansgiry S, Albo D, et al. Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease. J Surg Res. 2017;210:204–12.CrossRefPubMed Li L, Lau KS, Ramanathan V, Orcutt ST, Sansgiry S, Albo D, et al. Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease. J Surg Res. 2017;210:204–12.CrossRefPubMed
14.
go back to reference Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–36.CrossRefPubMedPubMedCentral Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–36.CrossRefPubMedPubMedCentral
15.
go back to reference Smith T, Noble M, Noble S, Wright G, McLennan D, Plunkett E. The English Indices of Deprivation 2015. London: Department of Communities & Local Government; 2015. p. 1–94. Smith T, Noble M, Noble S, Wright G, McLennan D, Plunkett E. The English Indices of Deprivation 2015. London: Department of Communities & Local Government; 2015. p. 1–94.
16.
go back to reference Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):34–45.CrossRefPubMedPubMedCentral Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):34–45.CrossRefPubMedPubMedCentral
17.
go back to reference Tomlinson LA, Riding AM, Payne RA, Abel GA, Tomson CR, Wilkinson IB, et al. The accuracy of diagnostic coding for acute kidney injury in England - a single centre study. BMC Nephrol. 2013;14:58.CrossRefPubMedPubMedCentral Tomlinson LA, Riding AM, Payne RA, Abel GA, Tomson CR, Wilkinson IB, et al. The accuracy of diagnostic coding for acute kidney injury in England - a single centre study. BMC Nephrol. 2013;14:58.CrossRefPubMedPubMedCentral
18.
go back to reference Hang J, Cai B, Xue P, Wang L, Hu H, Zhou Y, et al. The joint effects of lifestyle factors and comorbidities on the risk of colorectal cancer: a large chinese retrospective case-control study. PLoS One. 2015;10(12):e0143696.CrossRefPubMedPubMedCentral Hang J, Cai B, Xue P, Wang L, Hu H, Zhou Y, et al. The joint effects of lifestyle factors and comorbidities on the risk of colorectal cancer: a large chinese retrospective case-control study. PLoS One. 2015;10(12):e0143696.CrossRefPubMedPubMedCentral
19.
go back to reference Li PK, Burdmann EA, Mehta RL, World Kidney Day Steering C. Acute kidney injury: global health alert. Kidney Int. 2013;83(3):372–6.CrossRefPubMed Li PK, Burdmann EA, Mehta RL, World Kidney Day Steering C. Acute kidney injury: global health alert. Kidney Int. 2013;83(3):372–6.CrossRefPubMed
20.
go back to reference World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organisation; 2000. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organisation; 2000.
21.
go back to reference Kitchlu A, McArthur E, Amir E, Booth CM, Sutradhar R, Majeed H, et al. Acute kidney injury in patients receiving systemic treatment for cancer: a population-based cohort study. J Natl Cancer Inst. 2019;111(7):727–36.CrossRefPubMed Kitchlu A, McArthur E, Amir E, Booth CM, Sutradhar R, Majeed H, et al. Acute kidney injury in patients receiving systemic treatment for cancer: a population-based cohort study. J Natl Cancer Inst. 2019;111(7):727–36.CrossRefPubMed
22.
go back to reference White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med. 2010;29(28):2920–31.CrossRefPubMed White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med. 2010;29(28):2920–31.CrossRefPubMed
23.
go back to reference Benitez Majano S, Di Girolamo C, Rachet B, Maringe C, Guren MG, Glimelius B, et al. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study. Lancet Oncol. 2019;20(1):74–87.CrossRefPubMedPubMedCentral Benitez Majano S, Di Girolamo C, Rachet B, Maringe C, Guren MG, Glimelius B, et al. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study. Lancet Oncol. 2019;20(1):74–87.CrossRefPubMedPubMedCentral
24.
go back to reference Cheng Y, Nie S, Li L, Li Y, Liu D, Xiong M, et al. Epidemiology and outcomes of acute kidney injury in hospitalized cancer patients in China. Int J Cancer. 2019;144(11):2644–50.CrossRefPubMed Cheng Y, Nie S, Li L, Li Y, Liu D, Xiong M, et al. Epidemiology and outcomes of acute kidney injury in hospitalized cancer patients in China. Int J Cancer. 2019;144(11):2644–50.CrossRefPubMed
25.
go back to reference Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. The Lancet. 2019;394(10203):1041–54.CrossRef Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. The Lancet. 2019;394(10203):1041–54.CrossRef
26.
go back to reference Jagieła J, Bartnicki P, Rysz J. Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer, melanoma and non-small cell lung cancer. Int J Mol Sci. 2021;22(9):4618.CrossRefPubMedPubMedCentral Jagieła J, Bartnicki P, Rysz J. Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer, melanoma and non-small cell lung cancer. Int J Mol Sci. 2021;22(9):4618.CrossRefPubMedPubMedCentral
27.
go back to reference Savino M, Plumb L, Casula A, Evans K, Wong E, Kolhe N, et al. Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics. Pharmacoepidemiol Drug Saf. 2021;30(12):1687–95.CrossRefPubMed Savino M, Plumb L, Casula A, Evans K, Wong E, Kolhe N, et al. Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics. Pharmacoepidemiol Drug Saf. 2021;30(12):1687–95.CrossRefPubMed
28.
go back to reference Lim HJ, Zhang X, Dyck R, Osgood N. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes. BMC Med Res Methodol. 2010;10(1):97.CrossRefPubMedPubMedCentral Lim HJ, Zhang X, Dyck R, Osgood N. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes. BMC Med Res Methodol. 2010;10(1):97.CrossRefPubMedPubMedCentral
Metadata
Title
The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study
Authors
Kirsty Andresen
Helena Carreira
Helen Strongman
Helen I. McDonald
Sara Benitez-Majano
Kathryn E. Mansfield
Dorothea Nitsch
Laurie A. Tomlinson
Krishnan Bhaskaran
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11329-9

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine